NCT05023018Phase 2Recruiting

NEO100 and High-Grade Meningioma

Study sponsor: Neonc Technologies, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12-30Estimated
Enrollment · participants30Estimated
Source updated2026-09-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 30 Sep 2025. After: 30 Dec 2026.

Check registry source